Financial information

The information source is the annual report of the company with business id 556263-2769

* Closing information (×1000) SEK

Fiscal year 202312 202212 202112
Number of months: 12 12
Turnover: 42,986 Revenue Down 44,633 Revenue Down 46,098
Financial expenses: 6,871 Revenue Up 333 Revenue Up 23
Earnings before taxes: -57,010 Revenue Down -15,140 Revenue Down 6,259
Total assets: 361,147 Revenue Up 148,273 Revenue Up 37,816
Current assets: 342,076 Revenue Up 131,189 Revenue Up 34,745
Current liabilities: 46,966 Revenue Down 97,312 Revenue Up 21,716
Equity capital: 314,181 Revenue Up 50,961 Revenue Up 16,100
Share capital: 100 100 100
Number of employees: 56 Revenue Up 51 Revenue Up 29

Financial ratios

Solvency: 87.0% Revenue Up 34.4% Revenue Down 42.6%
Turnover per employee: 768 Revenue Down 875 Revenue Down 1,590
Profitability: -132.6% Revenue Down -33.9% Revenue Down 13.6%
Return on equity (ROE): -18.1% Revenue Up -29.7% Revenue Down 38.9%
Current ratio: 728.3% Revenue Up 134.8% Revenue Down 160.0%
Return on assets (ROA): -13.9% Revenue Down -10.0% Revenue Down 16.6%

Companies with similar products and services, and with detailed information

  • Solveco AB

    Pharmaceuticals. Medicinal chemicals. Botanical produc...

Fiscal year 202312
Number of months: 12
Turnover: 42,986
Financial expenses: 6,871
Earnings before taxes: -57,010
Total assets: 361,147
Current assets: 342,076
Current liabilities: 46,966
Equity capital: 314,181
Share capital: 100
Number of employees: 56

Financial ratios

Solvency: 87.0%
Turnover per employee: 768
Profitability: -132.6%
Return on equity (ROE): -18.1%
Current ratio: 728.3%
Return on assets (ROA): -13.9%